Meta‑analysis of the urokinase gene 3'‑UTR T/C polymorphism and susceptibility to urolithiasis

Li,Dawei; Liu,Jikai; Ren,Juchao; Yan,Lei; Liu,Hainan; Xu,Zhonghua

doi:10.3892/br.2013.73

Meta‑analysis of the urokinase gene 3'‑UTR T/C polymorphism and susceptibility to urolithiasis

Authors:
- Dawei Li
- Jikai Liu
- Juchao Ren
- Lei Yan
- Hainan Liu
- Zhonghua Xu
View Affiliations

Affiliations: Department of Urology, Qilu Hospital of Shandong University, Jinan, Shandong 250012, P.R. China
Published online on: March 7, 2013 https://doi.org/10.3892/br.2013.73
Pages: 369-374

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Urokinase is involved in the processes of initiating urinary stones. Several published case‑control studies have examined the relationship of urokinase gene 3'‑untranslated region (3'‑UTR) T/C polymorphism and urolithiasis, but yielded inconsistent findings. In this study, a comprehensive meta‑analysis was conducted by pooling relevant studies to obtain reliable conclusions. Studies focusing on the association between urokinase gene 3'‑UTR T/C polymorphism and urolithiasis were retrieved through PubMed, Medline, Web of Science and the China National Knowledge Infrastructure platform without any limit on language, until October 2012. Four independent articles were eventually identified as eligible for the final meta‑analysis, involving 1,195 subjects. Crude odds ratios (ORs), as well as 95% confidence intervals (CIs), were assessed for the association by either fixed- or random‑effects models using RevMan 5.0 software. Significant associations were noted in the ‘TC vs. CC’ codominant model for total population (OR=2.53; 95% CI, 1.43‑4.46; P=0.001), Asian population (OR=2.46; 95% CI, 1.38‑4.40; P=0.002), male (OR=2.98; 95% CI, 1.43‑6.21; P=0.004), Hardy‑Weinberg equilibrium (HWE) (OR=2.46; 95% CI, 1.38‑4.40; P=0.002) and recurrence (OR=2.66; 95% CI, 1.51‑4.67; P=0.00). Statistically significant associations were also observed in the ‘TT+TC vs. CC’ dominant model for the Asian, male, HWE and recurrence population (P<0.05). Additionally, a significant difference was detected in the ‘T vs. C’ allele model for HWE. However, there were no associations in either the ‘TT vs. CC’ codominant model or ‘TT vs. TC+CC’ recessive model. In conclusion, the present meta‑analysis suggests that urokinase gene T allele may increase the susceptibility of urolithiasis.

View Figures

View References

1	Johnson CM, Wilson DM, O’Fallon WM, Malek RS and Kurland LT: Renal stone epidemiology: a 25-year study in Rochester, Minnesota. Kidney Int. 16:624–631. 1979.PubMed/NCBI
2	Caudarella R, Tonello L, Rizzoli E and Vescini F: Predicting five-year recurrence rates of kidney stones: an artificial neural network model. Arch Ital Urol Androl. 83:14–19. 2011.PubMed/NCBI
3	Coe FL, Parks JH and Asplin JR: The pathogenesis and treatment of kidney stones. N Engl J Med. 327:1141–1152. 1992. View Article : Google Scholar : PubMed/NCBI
4	Goodman HO, Brommage R, Assimos DG and Holmes RP: Genes in idiopathic calcium oxalate stone disease. World J Urol. 15:186–194. 1997. View Article : Google Scholar : PubMed/NCBI
5	Wagner SN, Atkinson MJ, Wagner C, Höfler H, Schmitt M and Wilhelm O: Sites of urokinase-type plasminogen activator expression and distribution of its receptor in the normal human kidney. Histochem Cell Biol. 105:53–60. 1996. View Article : Google Scholar : PubMed/NCBI
6	Kitching AR, Holdsworth SR, Ploplis VA, et al: Plasminogen and plasminogen activators protect against renal injury in crescentic glomerulonephritis. J Exp Med. 185:963–968. 1997. View Article : Google Scholar : PubMed/NCBI
7	du Toit PJ, van Aswegen CH, Steyn PL, Pols A and du Plessis DJ: Effects of bacteria involved with the pathogenesis of infection-induced urolithiasis on the urokinase and sialidase (neuraminidase) activity. Urol Res. 20:393–397. 1992.
8	du Toit PJ, Van Aswegen CH, Steinmann CM, Klue L and Du Plessis DJ: Does urokinase play a role in renal stone formation? Med Hypotheses. 49:57–59. 1997.PubMed/NCBI
9	Loder N: Genetic variations can point the way to disease genes. Nature. 401:7341999. View Article : Google Scholar : PubMed/NCBI
10	Li D, Liu H, Yan L, Tang Y, Ren J and Xu Z: Lack of association between hOGG1 Ser326Cys polymorphism and the risk of bladder cancer: a meta-analysis. Urol Int. 88:88–94. 2012. View Article : Google Scholar : PubMed/NCBI
11	Li D, Tian T, Guo C, et al: No association of the MTHFR gene A1298C polymorphism with the risk of prostate cancer: a meta-analysis. Exp Ther Med. 3:493–498. 2012.PubMed/NCBI
12	Gögebakan B, Igci YZ, Arslan A, et al: Association between the T-593A and C6982T polymorphisms of the osteopontin gene and risk of developing nephrolithiasis. Arch Med Res. 41:442–448. 2010.PubMed/NCBI
13	Tripputi P, Blasi F, Verde P, Cannizzaro LA, Emanuel BS and Croce CM: Human urokinase gene is located on the long arm of chromosome 10. Proc Natl Acad Sci USA. 82:4448–4452. 1985. View Article : Google Scholar : PubMed/NCBI
14	Conne B, Berczy M and Belin D: Detection of polymorphisms in the human urokinase-type plasminogen activator gene. Thromb Haemost. 77:434–435. 1997.PubMed/NCBI
15	Shih CM, Kuo WH, Lin CW, et al: Association of polymorphisms in the genes of the urokinase plasminogen activation system with susceptibility to and severity of non-small cell lung cancer. Clin Chim Acta. 412:194–198. 2011. View Article : Google Scholar : PubMed/NCBI
16	Mittal RD, Srivastava DS and Mishra DK: Is urokinase gene 3′-UTR polymorphism associated with prostate cancer? Cancer Biomark. 1:287–292. 2005.
17	Manchanda PK, Bid HK and Mittal RD: Association of urokinase gene 3′-UTR T/C polymorphism with bladder cancer. Urol Int. 77:81–84. 2006.
18	Tsai FJ, Lin CC, Lu HF, Chen HY and Chen WC: Urokinase gene 3′-UTR T/C polymorphism is associated with urolithiasis. Urology. 59:458–461. 2002.
19	Ozturk M, Kordan Y, Cangul H, et al: Association of urokinase gene 3′-UTR T/C polymorphism with calcium oxalate urolithiasis in children. Int Urol Nephrol. 40:563–568. 2008.
20	Mittal RD, Bid HK, Kumar A and Bhandari M: Association of urokinase gene 3′-UTR polymorphism with calcium oxalate nephrolithiasis. J Endourol. 20:157–160. 2006.
21	Kim JY, Kim YS, Chang IH, Kim TH and Kim HR: Interleukin-1β, calcium-sensing receptor, and urokinase gene polymorphisms in korean patients with urolithiasis. Korean J Urol. 52:340–344. 2011.
22	Higgins JP, Thompson SG, Deeks JJ and Altman DG: Measuring inconsistency in meta-analyses. BMJ. 327:557–560. 2003. View Article : Google Scholar : PubMed/NCBI
23	Lee YH, Huang WC, Tsai JY, et al: Epidemiological studies on the prevalence of upper urinary calculi in Taiwan. Urol Int. 68:172–177. 2002. View Article : Google Scholar : PubMed/NCBI
24	van Aswegen CH, Dirksen van Sckalckwyk JC, du Toit PJ, Verster L, Franz RC and du Plessis DJ: The effect of calcium and magnesium ions on urinary urokinase and sialidase activity. Urol Res. 20:41–44. 1992.PubMed/NCBI
25	Wang S, Wang X, Wu J, et al: Association of vitamin D receptor gene polymorphism and calcium urolithiasis in the Chinese Han population. Urol Res. 40:277–284. 2012. View Article : Google Scholar : PubMed/NCBI
26	Klausner RD, Rouault TA and Harford JB: Regulating the fate of mRNA: the control of cellular iron metabolism. Cell. 72:19–28. 1993. View Article : Google Scholar : PubMed/NCBI
27	Chen K, Song F, Calin GA, Wei Q, Hao X and Zhang W: Polymorphisms in microRNA targets: a gold mine for molecular epidemiology. Carcinogenesis. 29:1306–1311. 2008. View Article : Google Scholar : PubMed/NCBI
28	Ha M, Pang M, Agarwal V and Chen ZJ: Interspecies regulation of microRNAs and their targets. Biochim Biophys Acta. 1779:735–742. 2008. View Article : Google Scholar : PubMed/NCBI